Name: HIV Diagnostics Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: CD4711
Price: 3750 USD
Availability: InStock

Hiv Diagnostics Testing Market Size, Share, Growth Report 2023- 2023

HIV Diagnostics Testing Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>HIV Diagnostics Testing Market is Segmented By Product(Consumables, Assays and Kits &amp; Reagents, Other Consumables, Instruments, Software &amp; Services), By Test Type(Antibody Tests, Viral Load Tests, CD4 Tests, Other), By Application(Diagnostic Laboratories, Hospitals, Other), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029.</h2>

&nbsp;

<blockquote>
HIV Diagnostics Testing Market&nbsp;is Predicted to reach&nbsp; at a <a href="https://www.datamintelligence.com/download-sample/hiv-diagnostics-testing-market">CAGR of 6.3% </a>during the forecast period (2022-2029). 
</blockquote>

HIV diagnostics are used to detect the human immunodeficiency virus in saliva, serum, or urine. HIV diagnostics aids in detecting antibodies, RNA, and antigens.

HIV Diagnostics Testing Market

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			6.3%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Product,&nbsp;By Test Type,&nbsp;By Application, and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

<h3>HIV Diagnostics Testing Market Dynamics</h3>

The factors influencing the global HIV diagnostics market are the increasing demand for HIV diagnostics, and the growing prevalence of HIV is expected to drive the market growth.

The increasing demand for HIV diagnostics &nbsp;is expected to drive market growth in the forecast period

The increasing awareness about HIV is expected to drive the demand for HIV diagnostics testing. For instance, India&#39;s AIDS Control Program is widely regarded as a success story worldwide. The National AIDS Control Programme (NACP) is being implemented as a comprehensive programme for HIV/AIDS prevention and control in India. Over time, the emphasis has shifted from raising awareness to behaviour change, from a national response to a more decentralized response, and increased involvement of NGOs and PLHIV networks to increased involvement of PLHIV networks.

Coordinated action is urgently needed in low- and middle-income countries (LMICs) with the highest HIV burden to ensure that the ambitious 90-90-90 HIV treatment targets set by the Joint United Nations Programme on HIV and AIDS are met. The targets anticipate that by 2020, 90 percent of people living with HIV will be aware of their status, 90 percent of those diagnosed with HIV will begin antiretroviral therapy (ART), and 90 percent of those receiving ART will have long-term viral suppression. Furthermore, the CDC recommends that everyone between 13 and 64 in the United States get tested for HIV at least once.

The drawbacks associated with HIV diagnostics &nbsp;testing is expected to hamper the market growth

The window period is one of the most serious issues with HIV testing (the time between a person being infected with HIV and their body producing enough antibodies for a test to detect). A negative test result could indicate that someone was recently infected with HIV. A positive test result can sometimes be a &#39;false positive,&#39; leading the person to believe they have HIV when they do not. A negative test result could be a &#39;false negative,&#39; implying that the person believes they do not have HIV when they do. The cost of testing is also one major reason expected to hamper the market. For instance, HIV testing is extremely expensive. It puts a strain on healthcare budgets in areas where resources are scarce. Except for blood transfusion services, where testing is required, the benefits of testing must be carefully considered. In addition, despite having enough trained counselors, the hospital lacks funds to cover the cost of testing kits, and the supply is unreliable.

<h3>COVID-19 Impact Analysis</h3>

Over the last year, the occurrence of the COVID-19 pandemic had a significant negative impact on healthcare systems. Healthcare providers were forced to focus primarily on COVID-19 patients, ignoring equally important diseases, both acute and chronic, in many cases. As a result, HIV screening and diagnostic strategies may have been significantly hampered. During the pandemic, there was a significant reduction in HIV diagnoses. People living with HIV during the pandemic, on the other hand, were older and diagnosed at an earlier stage of disease (based on CD4+ T cell count) than those diagnosed the previous year. Furthermore, there was a significant decrease in new HIV diagnoses among men who have sex with men, most likely due to the government&#39;s social distancing and restrictions. Even if the number of late presentations in 2020 is lower than in 2019, it remains an issue.

<h3>HIV Diagnostics Testing Market Segment Analysis</h3>

By test type, the antibody tests segment is expected to dominate the market 

HIV antibodies are detected in blood or saliva by the Antibody test. When bacteria or viruses enter the body, the immune system produces antibodies. After 3&ndash;12 weeks of infection, an HIV antibody test can determine if the person is positive. This can take several weeks or longer for the immune system to produce antibodies against HIV. With the kits, the patient can perform an HIV antibody test in the privacy of their own home. The majority of rapid and self-tests are antibody tests. In general, antibody tests using blood from a vein can detect HIV sooner than tests using blood from a finger prick or oral fluid.

Furthermore, on September 30th, 2020, Roche launched the Elecsys HIV Duo immunoassay in the United States. This test can detect an acute HIV infection earlier than current methods by measuring the HIV p24 antigen (the virus) and anti-HIV antibodies.

<h3>HIV Diagnostics Testing Market Geographical Analysis</h3>

North America region is expected to hold the largest market share in the global HIV diagnostics &nbsp;testing market

The presence of key players, the high prevalence of HIV/AIDS in the region, and established healthcare infrastructure are some of the key factors expected to drive the market in this region. According to the most recent Centers for Disease Control and Prevention estimates, 37,832 people in the United States were diagnosed with HIV in 2018. Furthermore, advantageous government initiatives and an increase in research collaborations. The CDC in the United States recommends routine HIV screening in healthcare settings for all adults aged 13 to 64, with at least annual repeat screening for those at higher risk.

<h3>HIV Diagnostics Testing Market Competitive Landscape</h3>

The global HIV diagnostics testing market is highly competitive with mergers, collaborations, and product launches. Some of the key players in the market are Siemens Healthineers, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson &amp; Company, Hologic Inc., JOYSBIO (Tianjin) Biotechnology Co., Ltd., and Bio-Rad Laboratories

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Frequently Asked Questions</h3>

What is the Projected CAGR value of the HIV Diagnostics Testing Market?

HIV Diagnostics Testing Market is expected to grow at a&nbsp;CAGR of 6.3%&nbsp;during the forecasting period 2022-2029.

Which region controlled the global market during 2022-2029?

North America&nbsp;region Controls&nbsp;the&nbsp;HIV Diagnostics Testing Market&nbsp;during 2022-2029

Which is the fastest growing region in the HIV Diagnostics Testing Market?

Among all regions,&nbsp;Asia Pacific&nbsp;is the fastest growing market share during the forecast period

<h3 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Trending Topics</h3>

<a href="https://www.datamintelligence.com/research-report/nuclear-imaging-market">Nuclear Imaging Market</a>

<a href="https://www.datamintelligence.com/research-report/vascular-imaging-market">Vascular Imaging Market</a>

<a href="https://www.datamintelligence.com/research-report/veterinary-imaging-market">Veterinary Imaging Market</a>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>
	<h3>Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3>Market Definition and Overview</h3>
	</li>
	<li>
	<h3>Executive Summary</h3>

	<ol>
		<li>Market Snippet By Product</li>
		<li>Market Snippet By Test Type</li>
		<li>Market Snippet By Application</li>
		<li>Market Snippet By Region</li>
	</ol>
	</li>
	<li>
	<h3>Market Dynamics</h3>

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers:
			<ol>
				<li>The increasing demand for HIV Diagnostics &nbsp;</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>The drawbacks associated with HIV Diagnostics &nbsp;testing</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Industry Analysis</h3>

	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	<h3>COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3>By Product &nbsp;</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
		<li>Market Attractiveness Index, By Product&nbsp;
		<ol>
			<li>Consumables
			<ol>
				<li>
				<ol>
					<li>Introduction</li>
					<li>Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
					<li>Assays and Kits &amp; Reagents</li>
					<li>Other Consumables&nbsp;</li>
					<li>Instruments</li>
					<li>Software &amp; Services</li>
				</ol>
				</li>
			</ol>
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>By Test Type</h3>

	<ol>
		<li>Introduction</li>
		<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type</li>
		<li>Market Attractiveness Index, By Test Type
		<ol>
			<li>Antibody Tests
			<ol>
				<li>
				<ol>
					<li>Introduction</li>
					<li>Market Size Analysis, US$ Mn, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
				</ol>
				</li>
			</ol>
			</li>
			<li>Viral Load Tests</li>
			<li>CD4 Tests</li>
			<li>Other</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Diagnostic Laboratories*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028</li>
		</ol>
		</li>
		<li>&nbsp;Hospitals</li>
		<li>&nbsp;Other</li>
	</ol>
	</li>
	<li>
	<h3>By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2019-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3>Competitive Landscape</h3>

	<ol>
		<li>&nbsp;Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
	</ol>
	</li>
	<li>
	<h3>Company Profiles</h3>
	</li>
</ol>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12.1.&nbsp;&nbsp; F. Hoffmann-La Roche Ltd

<ol>
	<li>Company Overview
	<ol>
		<li>Product Portfolio and Description
		<ol>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Siemens Healthineers</li>
		<li>Abbott Laboratories</li>
		<li>Merck KGaA</li>
		<li>&nbsp;Danaher Corporation</li>
		<li>Becton, Dickinson &amp; Company</li>
		<li>Hologic Inc.</li>
		<li>Thermo Fisher Scientific</li>
		<li>Bio-Rad Laboratories</li>
		<li>JOYSBIO (Tianjin) Biotechnology Co., Ltd.(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
</ol>

<h3>13 DataM Intelligence&nbsp;&nbsp;</h3>

<ol>
	<li>Appendix</li>
	<li>About Us and Services</li>
	<li>Contact Us&nbsp;</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables &amp; Figures</h2>

List of Tables

Table 01 Global HIV Diagnostics Testing Market, By Product, 2021, 2025 &amp; 2029 ($ Million)

Table 02 Global HIV Diagnostics Testing Market, By Test Type, 2021, 2025 &amp; 2029 ($ Million)

Table 03 Global HIV Diagnostics Testing Market Value, By Application, 2021, 2025 &amp; 2029 ($ Million)

Table 04 Global HIV Diagnostics Testing Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 05 Global HIV Diagnostics Testing Market Value, By Product , 2021, 2025 &amp; 2029 ($ Million)

Table 06 Global HIV Diagnostics Testing Market Value, By Product , 2021, 2025 &amp; 2029 ($ Million)

Table 07 Global HIV Diagnostics Testing Market Value, By Test Type, 2021, 2025 &amp; 2029 ($ Million)

Table 08 Global HIV Diagnostics Testing Market Value, By Test Type, 2019-2029 ($ Million)

Table 09 Global HIV Diagnostics Testing Market Value, By Application, 2021, 2025 &amp; 2029 ($ Million)

Table 10 Global HIV Diagnostics Testing Market Value, By Application, 2019-2029 ($ Million)

Table 11&nbsp;&nbsp; Global HIV Diagnostics Testing Market Value, By Region, 2021, 2025 &amp; 2029 ($ Million)

Table 12 Global HIV Diagnostics Testing Market Value, By Region, 2019-2029 ($ Million)

Table 13 North America HIV Diagnostics Testing Market Value, By Product , 2019-2029 ($ Million)

Table 14 North America HIV Diagnostics Testing Market Value, By Test Type, 2019-2029 ($ Million)

Table 15 North America HIV Diagnostics Testing Market Value, By Application, 2019-2029 ($ Million)

Table 16 North America HIV Diagnostics Testing Market Value, By Country, 2019-2029 ($ Million)

Table 17 South America HIV Diagnostics Testing Market Value, By Product , 2019-2029 ($ Million)

Table 18 South America HIV Diagnostics Testing Market Value, By Test Type, 2019-2029 ($ Million)

Table 19 South America HIV Diagnostics Testing Market Value, By Application, 2019-2029 ($ Million)

Table 20 South America HIV Diagnostics Testing Market Value, By Country, 2019-2029 ($ Million)

Table 21 Europe HIV Diagnostics Testing Market Value, By Product , 2019-2029 ($ Million)

Table 22 Europe HIV Diagnostics Testing Market Value, By Test Type, 2019-2029 ($ Million)

Table 23 Europe HIV Diagnostics Testing Market Value, By Application, 2019-2029 ($ Million)

Table 24 Europe HIV Diagnostics Testing Market Value, By Country, 2019-2029 ($ Million)

Table 25 Asia-Pacific HIV Diagnostics Testing Market Value, By Product , 2019-2029 ($ Million)

Table 26 Asia-Pacific HIV Diagnostics Testing Market Value, By Test Type, 2019-2029 ($ Million)

Table 27 Asia-Pacific HIV Diagnostics Testing Market Value, By Application, 2019-2029 ($ Million)

Table 28 Asia-Pacific HIV Diagnostics Testing Market Value, By Country, 2019-2029 ($ Million)

Table 29 Middle East &amp; Africa HIV Diagnostics Testing Market Value, By Product , 2019-2029 ($ Million)

Table 30 Middle East &amp; Africa HIV Diagnostics Testing Market Value, By Test Type, 2019-2029 ($ Million)

Table 31 Middle East &amp; Africa HIV Diagnostics Testing Market Value, By Application, 2019-2029 ($ Million)

Table 32 F. Hoffmann-La Roche Ltd: Overview

Table 33 F. Hoffmann-La Roche Ltd: Product Portfolio

Table 34 F. Hoffmann-La Roche Ltd: Key Developments

Table 35 Siemens Healthineers: Overview

Table 36 Siemens Healthineers: Product Portfolio

Table 37 Siemens Healthineers: Key Developments

Table 38 Abbott Laboratories: Overview

Table 39 Abbott Laboratories: Product Portfolio

Table 40 Abbott Laboratories: Key Developments

Table 41 Merck KGaA: Overview

Table 42 Merck KGaA: Product Portfolio

Table 43 Merck KGaA: Key Developments

Table 44 Danaher Corporation: Overview

Table 45 Danaher Corporation: Product Portfolio

Table 46 Danaher Corporation: Key Developments

Table 47 Becton, Dickinson &amp; Company: Overview

Table 48 Becton, Dickinson &amp; Company: Product Portfolio

Table 49 Becton, Dickinson &amp; Company: Key Developments

Table 50 Hologic Inc.: Overview

Table 51 Hologic Inc.: Product Portfolio

Table 52 Hologic Inc.: Key Developments

Table 53 Thermo Fisher Scientific: Overview

Table 54 Thermo Fisher Scientific: Product Portfolio

Table 55 Thermo Fisher Scientific: Key Developments

Table 56 Bio-Rad Laboratories: Overview

Table 57 Bio-Rad Laboratories: Product Portfolio

Table 58 Bio-Rad Laboratories: Key Developments

Table 59 JOYSBIO (Tianjin) Biotechnology Co., Ltd.: Overview

Table 60 JOYSBIO (Tianjin) Biotechnology Co., Ltd.: Product Portfolio

Table 61 JOYSBIO (Tianjin) Biotechnology Co., Ltd.: Key Developments

List of Figures

Figure 01 Global HIV Diagnostics Testing Market Share, By Product , 2021 &amp; 2029 (%)

Figure 02 Global HIV Diagnostics Testing Market Share, By Test Type, 2021 &amp; 2029 (%)

Figure 03 Global HIV Diagnostics Testing Market Share, By Application, 2021 &amp; 2029 (%)

Figure 04 Global HIV Diagnostics Testing Market Share, By Region, 2021 &amp; 2029 (%)

Figure 05 Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 06 Global HIV Diagnostics Testing Market Y-o-Y Growth By Product , 2021-2029 (%)

Figure 07 Consumables: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 08 Instruments: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 09 Software &amp; Services: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 10 Global HIV Diagnostics Testing Market Y-o-Y Growth By Test Type, 2021-2029 (%)

Figure 11 Antibody Tests: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 12 Viral Load Tests: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 13 CD4 Tests: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 14 Other: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 15 Global HIV Diagnostics Testing Market Y-o-Y Growth By Application, 2021-2029 (%)

Figure 16 Diagnostic Laboratories: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 17 Hospitals: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 18 Other: Global HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 19 Global HIV Diagnostics Testing Market Y-o-Y Growth By Region, 2021-2029 (%)

Figure 20 North America HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 21 North America HIV Diagnostics Testing Market Share, By Product , 2021 &amp; 2029 (%)

Figure 22 North America HIV Diagnostics Testing Market Share, By Test Type, 2021 &amp; 2029 (%)

Figure 23 North America HIV Diagnostics Testing Market Share, By Application, 2021 &amp; 2029 (%)

Figure 24 North America HIV Diagnostics Testing Market Share, By Country, 2021 &amp; 2029 (%)

Figure 25 South America HIV Diagnostics Testing Market Share, 2019-2029 ($ Million)

Figure 26 South America HIV Diagnostics Testing Market Share, By Product , 2021 &amp; 2029 (%)

Figure 27 South America HIV Diagnostics Testing Market Share, By Test Type, 2021 &amp; 2029 (%)

Figure 28 South America HIV Diagnostics Testing Market Share, By Application, 2021 &amp; 2029 (%)

Figure 29 South America HIV Diagnostics Testing Market Share, By Country, 2021 &amp; 2029 (%)

Figure 30 Europe HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 31 Europe HIV Diagnostics &nbsp;Testing Market Share, By Product , 2021 &amp; 2029 (%)

Figure 32 Europe HIV Diagnostics Testing Market Share, By Test Type, 2021 &amp; 2029 (%)

Figure 33 Europe HIV Diagnostics Testing Market Share, By Application, 2021 &amp; 2029 (%)

Figure 34 Europe HIV Diagnostics Testing Market Share, By Country, 2021 &amp; 2029 (%)

Figure 35 Asia-Pacific HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 36 Asia-Pacific HIV Diagnostics Testing Market Share, By Product , 2021 &amp; 2029 (%)

Figure 37 Asia-Pacific HIV Diagnostics Testing Market Share, By Test Type, 2021 &amp; 2029 (%)

Figure 38 Asia-Pacific HIV Diagnostics Testing Market Share, By Application, 2021 &amp; 2029 (%)

Figure 39 Asia-Pacific HIV Diagnostics Testing Market Share, By Country, 2021 &amp; 2029 (%)

Figure 40 Middle East &amp; Africa HIV Diagnostics Testing Market Value, 2019-2029 ($ Million)

Figure 41 Middle East &amp; Africa HIV Diagnostics &nbsp;Testing Market Share, By Product , 2021 &amp; 2029 (%)

Figure 42 Middle East &amp; Africa HIV Diagnostics Testing Market Share, By Test Type, 2021 &amp; 2029 (%)

Figure 43 Middle East &amp; Africa HIV Diagnostics Testing Market Share, By Application, 2021 &amp; 2029 (%)

Figure 44 F. Hoffmann-La Roche Ltd: Financials

Figure 45 Siemens Healthineers: Financials

Figure 46 Abbott Laboratories: Financials

Figure 47 Merck KGaA: Financials

Figure 48 Danaher Corporation: Financials

Figure 49 Becton, Dickinson &amp; Company: Financials

Figure 50 Hologic Inc.: Financials

Figure 51 Thermo Fisher Scientific: Financials

Figure 52 Bio-Rad Laboratories: Financials

Figure 53 JOYSBIO (Tianjin) Biotechnology Co., Ltd.: Financials